ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Hematology Oncology

Top Hematology Oncology Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
YUN HEE CHUNG MD

Hematology Oncology

26,314

$4.4M

901
852 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 24%

$167
Average prescription price

Avg: $364

WILLIAM CHEUNG M.D.

Hematology Oncology

14,654

$2.29M

770
698 are 65+

2%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 24%

$156
Average prescription price

Avg: $364

IRENA PLESKOVA MD

Hematology Oncology

13,568

$1.95M

232
214 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

67%
prescriptions for brand name drugs

Avg: 24%

$144
Average prescription price

Avg: $364

ERIC RISHE MD

Hematology Oncology

9,977

$1.85M

500
370 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

2%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 24%

$185
Average prescription price

Avg: $364

AFTABAHMED SHAIKH MD

Hematology Oncology

8,378

$399K

312
221 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $364

HAI SUN PARK M.D.

Hematology Oncology

8,361

$1.66M

385
358 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 24%

$199
Average prescription price

Avg: $364

JYMING WANG M.D.

Hematology Oncology

7,067

$503K

438
407 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $364

ABDUL KHUWAJA MD

Hematology Oncology

6,899

$1.28M

233
207 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$185
Average prescription price

Avg: $364

JOSEPH AMENT M.D.

Hematology Oncology

6,829

$601K

246
206 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$88
Average prescription price

Avg: $364

MIR IQBAL MD

Hematology Oncology

5,868

$527K

108
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $364

RICHARD GELTMAN MD

Hematology Oncology

4,625

$411K

309
299 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $364

FRANCOIS BRUTUS MD

Hematology Oncology

4,616

$242K

124
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $364

VIRGILIO CEPELLOS M.D.

Hematology Oncology

4,449

$340K

232
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $364

LUCY SOURIAL MD

Hematology Oncology

4,038

$453K

203
170 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $364

AMER RAFIAA M.D.

Hematology Oncology

4,024

$783K

166
145 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$195
Average prescription price

Avg: $364

SWEETY MARFATIA MD

Hematology Oncology

3,978

$191K

74
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $364

SHOUKRI WISA MD

Hematology Oncology

3,944

$743K

263
212 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$188
Average prescription price

Avg: $364

NORLAND NG M.D.

Hematology Oncology

3,940

$2.66M

505
438 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 24%

$676
Average prescription price

Avg: $364

BER-YUH YANG M.D.

Hematology Oncology

3,647

$2.25M

196
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 24%

$617
Average prescription price

Avg: $364

JEAN DAUGUSTINE MD

Hematology Oncology

3,601

$232K

164
120 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $364

JOSE CERVANTES MD

Hematology Oncology

3,259

$500K

259
203 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$153
Average prescription price

Avg: $364

PRITI MANDALAYWALA MD

Hematology Oncology

3,081

$374K

166
96 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $364

ROBERT DINSMORE MD

Hematology Oncology

2,999

$471K

292
253 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$157
Average prescription price

Avg: $364

VICTOR RIBEIRO MD

Hematology Oncology

2,840

$134K

162
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $364

MADHUMATI KALAVAR MD

Hematology Oncology

2,821

$1.55M

199
157 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$549
Average prescription price

Avg: $364

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank